粪便微生物群移植捐赠者的经历与态度：一项来自中国的实证性生物伦理学研究。
Donors' experiences and attitudes of fecal microbiota transplantation: An empirical bioethics study from China.
作者信息
Ma Yonghui, Ke Dawei, Li Danyi, Zhang Quan
机构信息
Medical Humanities and Bioethics Center, School of Medicine Xiamen University Xiamen China.
R Institute Co. Ltd. Beijing China.
出版信息
Imeta. 2022 Nov 21;1(4):e62. doi: 10.1002/imt2.62. eCollection 2022 Dec.
Abstract
Donor participation is a critical part of ensuring the development of human microbiome research and the clinical application of fecal microbiota transplantation (FMT). Most FMT donors are still not sufficiently aware of the risks associated with the act of donating gut microbiota, especially the risk of data privacy disclosure. Enhanced awareness of the moral responsibility of the researchers and ethical oversight by ethics committees are needed.
摘要
供体参与是确保人类微生物组研究发展和粪便微生物群移植（FMT）临床应用的关键部分。大多数FMT供体仍未充分意识到捐赠肠道微生物群行为所带来的风险，尤其是数据隐私泄露的风险。需要提高研究人员的道德责任感，并加强伦理委员会的伦理监督。
相似文献
1
Donors' experiences and attitudes of fecal microbiota transplantation: An empirical bioethics study from China.粪便微生物群移植捐赠者的经历与态度：一项来自中国的实证性生物伦理学研究。
Imeta. 2022 Nov 21;1(4):e62. doi: 10.1002/imt2.62. eCollection 2022 Dec.
2
How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study.中国临床医生如何应对粪便微生物群移植中的伦理和社会挑战：一项问卷调查研究
BMC Med Ethics. 2017 May 31;18(1):39. doi: 10.1186/s12910-017-0200-2.
3
Fecal microbiota transplantation alters gut phage communities in a clinical trial for obesity.粪便微生物群移植改变了肥胖症临床试验中的肠道噬菌体群落。
Microbiome. 2024 Jul 6;12(1):122. doi: 10.1186/s40168-024-01833-w.
4
A comprehensive approach to stool donor screening for faecal microbiota transplantation in China.中国粪便微生物群移植中粪便供体筛查的综合方法。
Microb Cell Fact. 2021 Nov 27;20(1):216. doi: 10.1186/s12934-021-01705-0.
5
Donor age and body weight determine the effects of fecal microbiota transplantation on growth performance, and fecal microbiota development in recipient pigs.供体年龄和体重决定了粪便微生物群移植对受体猪生长性能和粪便微生物群发育的影响。
J Anim Sci Biotechnol. 2022 Apr 11;13(1):49. doi: 10.1186/s40104-022-00696-1.
6
A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process.一种用于粪菌移植治疗溃疡性结肠炎的供体选择匹配策略：荟萃分析和层次分析法。
Microbiol Spectr. 2023 Feb 14;11(1):e0215921. doi: 10.1128/spectrum.02159-21. Epub 2022 Dec 6.
7
Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes.衰老对粪菌移植供体粪便微生物群组成的影响及其对临床结局的影响。
Dig Dis Sci. 2017 Apr;62(4):1002-1008. doi: 10.1007/s10620-017-4449-6. Epub 2017 Feb 8.
8
Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies.在鼠类微生物组研究中进行粪便微生物群移植的程序。
Front Cell Infect Microbiol. 2021 Sep 21;11:711055. doi: 10.3389/fcimb.2021.711055. eCollection 2021.
9
Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection.复发性艰难梭菌感染儿童粪便微生物群移植后的临床疗效和微生物组变化
Front Microbiol. 2018 Nov 2;9:2622. doi: 10.3389/fmicb.2018.02622. eCollection 2018.
10
Knowledge, attitudes, ethical and social perspectives towards fecal microbiota transplantation (FMT) among Jordanian healthcare providers.约旦医疗保健提供者对粪便微生物群移植（FMT）的知识、态度、伦理和社会观点。
BMC Med Ethics. 2021 Feb 27;22(1):19. doi: 10.1186/s12910-021-00587-6.
引用本文的文献
1
Fecal Microbiota Transplantation: Insights into Colon Carcinogenesis and Immune Regulation.粪便微生物群移植：对结肠癌发生和免疫调节的见解。
J Clin Med. 2024 Nov 1;13(21):6578. doi: 10.3390/jcm13216578.
本文引用的文献
1
Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank.粪便银行用于粪便微生物群移植：大型粪便银行的方法和操作。
Front Cell Infect Microbiol. 2021 Apr 15;11:622949. doi: 10.3389/fcimb.2021.622949. eCollection 2021.
2
Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor.粪便微生物群移植：筛选与选择以挑选最佳供体
J Clin Med. 2020 Jun 5;9(6):1757. doi: 10.3390/jcm9061757.
3
FMT and Microbial Medical Products: Generating High-Quality Evidence through Good Governance.粪菌移植与微生物医疗产品：通过良好治理产生高质量证据。
J Law Med Ethics. 2019 Dec;47(4):505-523. doi: 10.1177/1073110519897727.
4
The Impact of Regulatory Policies on the Future of Fecal Microbiota Transplantation.监管政策对粪便微生物群移植未来的影响。
J Law Med Ethics. 2019 Dec;47(4):482-504. doi: 10.1177/1073110519897726.
5
Ethical implications of recruiting universal stool donors for faecal microbiota transplantation.招募通用粪便供体进行粪便微生物群移植的伦理问题。
Lancet Infect Dis. 2020 Mar;20(3):e44-e49. doi: 10.1016/S1473-3099(19)30569-9. Epub 2019 Nov 26.
6
The Super-Donor Phenomenon in Fecal Microbiota Transplantation.粪便微生物移植中的超级供体现象。
Front Cell Infect Microbiol. 2019 Jan 21;9:2. doi: 10.3389/fcimb.2019.00002. eCollection 2019.
7
The use of faecal microbiota transplant as treatment for recurrent or refractory infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.粪便微生物群移植作为治疗复发性或难治性感染及其他潜在适应证的应用：联合英国胃肠病学会（BSG）和医疗保健感染学会（HIS）指南。
Gut. 2018 Nov;67(11):1920-1941. doi: 10.1136/gutjnl-2018-316818. Epub 2018 Aug 28.
8
Help, hope and hype: ethical considerations of human microbiome research and applications.帮助、希望与炒作：人类微生物组研究及应用的伦理考量
Protein Cell. 2018 May;9(5):404-415. doi: 10.1007/s13238-018-0537-4.
9
A systematic review of incentives in blood donation.献血激励措施的系统评价。
Transfusion. 2018 Jan;58(1):242-254. doi: 10.1111/trf.14387. Epub 2017 Nov 6.
10
The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis.供体肠道微生物群的分类组成是影响粪便微生物群移植治疗难治性溃疡性结肠炎疗效的主要因素。
Aliment Pharmacol Ther. 2018 Jan;47(1):67-77. doi: 10.1111/apt.14387. Epub 2017 Oct 20.
Zotero 插件